Home » Topics » Regulatory » EMA

EMA
RSS

Simponi gets positive opinion in Europe for ulcerative colitis

July 30, 2013

Stelara receives positive CHMP recommendation

July 30, 2013

Eisai receives positive CHMP opinion for Zonegran in pediatric patients

July 30, 2013

Gilead receives positive opinion from EMA for cobicistat

July 29, 2013

Novartis' dual bronchodilator QVA-149 recommended for approval in COPD by CHMP

July 29, 2013

EMA issues negative opinion on delamanid for tuberculosis

July 29, 2013

EMA committee recommends approval of Revolade expanded indication

July 29, 2013

EMA's CHMP recommends approval of VEGF Trap-Eye/Eylea for new indication

July 29, 2013

EMA committee recommends Defitelio approval under exceptional circumstances

July 29, 2013

CHMP confirms Xeljanz recommendation

July 26, 2013

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 16, 2026.
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
Keros reports beneficial effects of RKER-065 in ALS model
BioWorld Science
Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
First-in-class POLG activator restores mtDNA across mutations
BioWorld Science
Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...